Skip to main content
Clinical Trials/JPRN-jRCT2080223308
JPRN-jRCT2080223308UnknownPhase 3

A phase III clinical study of HFT-290 in patients with cancer pain.

Hisamitsu Pharmaceutical Co.,Inc.0 sitesStarted: September 1, 2016Last updated:
Conditions

Trial Snapshot

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Patients with a diagnosis of cancer who are informed about their disease.

Exclusion Criteria

  • - Patients with abnormalities at the target application site.
  • - Patients with serious cardiac, hepatic, or renal dysfunction, serious respiratory disease, or serious respiratory depression.

Investigators

Similar Trials